2020 SOHO Updates on IO in Aggressive B-nHL: What Is the ORR With Mosunetuzumab/Odronextamab in R/R Disease? How Does Dosing of Glofitamab Affect Anti-Tumor Activity?
SOHO 2020 on-demand content is available through January 12, 2021. To access the virtual environment, ...
read more ↘
read more ↘
Comments 0
Login to view comments.
Click here to Login
